Not all people with CLL have to have therapy. Irrespective of all the latest innovations, the iwCLL nonetheless recommends watchful observation for patients with asymptomatic sickness.86 This advice relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F